Abstract P533: Incidence and Outcomes of Thrombectomy Rescue Therapies in Acute Basilar Artery Occlusions

BackgroundHematoma expansion (HE) is an important therapeutic target in intracerebral hemorrhage. Recently proposed HE definitions have not been validated, and no previous definition has accounted for withdrawal of care (WOC). ObjectiveTo compare conventional and revised definitions of hematoma expa...

Full description

Saved in:
Bibliographic Details
Published inStroke (1970) Vol. 52; no. Suppl_1; p. AP533
Main Authors Lun, Ronda, Walker, Greg B, Weisenburger-Lile, David, Lapergue, Bertrand, Guenego, Adrien, heran, navraj s, Siu, William, Dargazanli, Cyril, Benali, Amel, Gory, Benjamin, Richard, Sebastien, Ducroux, Celina, Piotin, Michel, BLANC, RAPHAEL, Labreuche, Julien, Lucas, Ludovic, Haddad, John, Aubertin, Mathilde, vannier, stephane, Guillen, Maud, Eugene, Francois, Maier, Benjamin, Marnat, Gaultier, Detraz, Lili, Bourcier, Romain, FAHED, Robert
Format Journal Article
LanguageEnglish
Published Lippincott Williams & Wilkins 01.03.2021
Online AccessGet full text
ISSN0039-2499
1524-4628
DOI10.1161/str.52.suppl_1.P533

Cover

Abstract BackgroundHematoma expansion (HE) is an important therapeutic target in intracerebral hemorrhage. Recently proposed HE definitions have not been validated, and no previous definition has accounted for withdrawal of care (WOC). ObjectiveTo compare conventional and revised definitions of hematoma expansion (HE), while accounting for WOC. MethodsWe analyzed data from the ATACH-2 trial, comparing revised definitions of HE incorporating intraventricular hemorrhage (IVH) expansion to the conventional definition of “≥6 mL or ≥33%”. The primary outcome was modified Rankin Scale of 4-6 at 90-days. We calculated the incidence, sensitivity, specificity, positive and negative predictive values, and c-statistic for all definitions of HE. Definitions were compared using non-parametric methods. Secondary analyses were performed after removing patients who experienced WOC. ResultsPrimary analysis included 948 patients. Using the conventional definition, the sensitivity was 37.1% and specificity was 83.2% for the primary outcome. Sensitivity improved with all three revised definitions (53.3%, 48.7%, and 45.3%, respectively), with minimal change to specificity (78.4%, 80.5%, and 81.0%, respectively). The greatest improvement was seen with the definition “≥6 mL or ≥33% or any IVH”, with increased c-statistic from 60.2% to 65.9% (p < 0.001). Secondary analysis excluded 46 participants who experienced WOC. The revised definitions outperformed the conventional definition in this population as well, with the greatest improvement in c-statistic using “≥6 mL or ≥33% or any IVH” (58.1% vs 64.1%, p < 0.001). ConclusionsHE definitions incorporating intraventricular expansion outperformed conventional definitions for predicting poor outcome, even after accounting for care limitations.
AbstractList BackgroundHematoma expansion (HE) is an important therapeutic target in intracerebral hemorrhage. Recently proposed HE definitions have not been validated, and no previous definition has accounted for withdrawal of care (WOC). ObjectiveTo compare conventional and revised definitions of hematoma expansion (HE), while accounting for WOC. MethodsWe analyzed data from the ATACH-2 trial, comparing revised definitions of HE incorporating intraventricular hemorrhage (IVH) expansion to the conventional definition of “≥6 mL or ≥33%”. The primary outcome was modified Rankin Scale of 4-6 at 90-days. We calculated the incidence, sensitivity, specificity, positive and negative predictive values, and c-statistic for all definitions of HE. Definitions were compared using non-parametric methods. Secondary analyses were performed after removing patients who experienced WOC. ResultsPrimary analysis included 948 patients. Using the conventional definition, the sensitivity was 37.1% and specificity was 83.2% for the primary outcome. Sensitivity improved with all three revised definitions (53.3%, 48.7%, and 45.3%, respectively), with minimal change to specificity (78.4%, 80.5%, and 81.0%, respectively). The greatest improvement was seen with the definition “≥6 mL or ≥33% or any IVH”, with increased c-statistic from 60.2% to 65.9% (p < 0.001). Secondary analysis excluded 46 participants who experienced WOC. The revised definitions outperformed the conventional definition in this population as well, with the greatest improvement in c-statistic using “≥6 mL or ≥33% or any IVH” (58.1% vs 64.1%, p < 0.001). ConclusionsHE definitions incorporating intraventricular expansion outperformed conventional definitions for predicting poor outcome, even after accounting for care limitations.
Abstract only Background: Hematoma expansion (HE) is an important therapeutic target in intracerebral hemorrhage. Recently proposed HE definitions have not been validated, and no previous definition has accounted for withdrawal of care (WOC). Objective: To compare conventional and revised definitions of hematoma expansion (HE), while accounting for WOC. Methods: We analyzed data from the ATACH-2 trial, comparing revised definitions of HE incorporating intraventricular hemorrhage (IVH) expansion to the conventional definition of “≥6 mL or ≥33%”. The primary outcome was modified Rankin Scale of 4-6 at 90-days. We calculated the incidence, sensitivity, specificity, positive and negative predictive values, and c- statistic for all definitions of HE. Definitions were compared using non-parametric methods. Secondary analyses were performed after removing patients who experienced WOC. Results: Primary analysis included 948 patients. Using the conventional definition, the sensitivity was 37.1% and specificity was 83.2% for the primary outcome. Sensitivity improved with all three revised definitions (53.3%, 48.7%, and 45.3%, respectively), with minimal change to specificity (78.4%, 80.5%, and 81.0%, respectively). The greatest improvement was seen with the definition “≥6 mL or ≥33% or any IVH”, with increased c -statistic from 60.2% to 65.9% (p < 0.001). Secondary analysis excluded 46 participants who experienced WOC. The revised definitions outperformed the conventional definition in this population as well, with the greatest improvement in c -statistic using “≥6 mL or ≥33% or any IVH” (58.1% vs 64.1%, p < 0.001). Conclusions: HE definitions incorporating intraventricular expansion outperformed conventional definitions for predicting poor outcome, even after accounting for care limitations.
Author Walker, Greg B
Guenego, Adrien
Guillen, Maud
Piotin, Michel
FAHED, Robert
Lun, Ronda
Benali, Amel
Ducroux, Celina
vannier, stephane
Eugene, Francois
Detraz, Lili
Dargazanli, Cyril
Haddad, John
Aubertin, Mathilde
Weisenburger-Lile, David
Richard, Sebastien
Lapergue, Bertrand
heran, navraj s
Lucas, Ludovic
BLANC, RAPHAEL
Labreuche, Julien
Bourcier, Romain
Maier, Benjamin
Marnat, Gaultier
Gory, Benjamin
Siu, William
AuthorAffiliation Chu Nantes HGRL, Saint Herblain, France
Vancouver, Canada
FOCH Hosp, Suresnes, France
Dept of Neuroradiology, Cntr Hospier Universitaire Gui de Chauliac, Montpellier, France
Neurovascular Unit, Foch Hosp–Suresnes, Suresnes, France
Dept of Interventional Neuroradiology, Fondation Rothschild Hosp, Paris, France
Lille, France
CHRU NANCY, Nancy, France
Rothschild Foundation, Paris, France
Neurovascular Unit, Cntr Hospier Universitaire Pontchaillou, Rennes, France
The Ottawa Hosp, Ottawa, Canada
Dept of Medicine: Div of Neurology, Stroke Program, The Ottawa Hosp, Ottawa, Canada
Fraser Health Authority, New Westminster, Canada
Dept of Neuroradiology, Cntr Hospier Universitaire de Bordeaux, Bordeaux, France
RENNES, France
Dept of Medicine: Div of Neurology, Stroke Program, Université de Lorraine, CHRU-Nancy, F-54000 Nancy, France, France
Neurovascular Unit, Cntr Hospier Universitaire de Bordeaux, Bordeaux, France
PIERRE PAUL RIQUET HOSPITAL, Toulouse, France
Doctor of Medicine Program, Univ of Ottawa, Ottawa,
AuthorAffiliation_xml – name: RENNES, France
– name: Dept of Neuroradiology, Cntr Hospier Universitaire de Bordeaux, Bordeaux, France
– name: CHRU NANCY, Nancy, France
– name: Lille, France
– name: Neurovascular Unit, Cntr Hospier Universitaire Pontchaillou, Rennes, France
– name: Dept of Interventional Neuroradiology, Fondation Rothschild Hosp, Paris, France
– name: Dept of Medicine: Div of Neurology, Stroke Program, The Ottawa Hosp, Ottawa, Canada
– name: PIERRE PAUL RIQUET HOSPITAL, Toulouse, France
– name: Dept of Medicine: Div of Neurology, Stroke Program, Université de Lorraine, CHRU-Nancy, F-54000 Nancy, France, France
– name: Doctor of Medicine Program, Univ of Ottawa, Ottawa, Canada
– name: Fraser Health Authority, New Westminster, Canada
– name: The Ottawa Hosp, Ottawa, Canada
– name: Neurovascular Unit, Foch Hosp–Suresnes, Suresnes, France
– name: Chu Nantes HGRL, Saint Herblain, France
– name: Dept of Diagnostic and Therapeutic Neuroradiology, Univ Hosp of Nantes, L’institut du thorax, Nantes, France
– name: Vancouver, Canada
– name: Neurovascular Unit, Cntr Hospier Universitaire de Bordeaux, Bordeaux, France
– name: Rothschild Foundation, Paris, France
– name: Dept of Neuroradiology, Cntr Hospier Universitaire Gui de Chauliac, Montpellier, France
– name: FOCH Hosp, Suresnes, France
Author_xml – sequence: 1
  givenname: Ronda
  surname: Lun
  fullname: Lun, Ronda
  organization: Dept of Medicine: Div of Neurology, Stroke Program, The Ottawa Hosp, Ottawa, Canada
– sequence: 2
  givenname: Greg B
  surname: Walker
  fullname: Walker, Greg B
  organization: Vancouver, Canada
– sequence: 3
  givenname: David
  surname: Weisenburger-Lile
  fullname: Weisenburger-Lile, David
  organization: Neurovascular Unit, Foch Hosp–Suresnes, Suresnes, France
– sequence: 4
  givenname: Bertrand
  surname: Lapergue
  fullname: Lapergue, Bertrand
  organization: FOCH Hosp, Suresnes, France
– sequence: 5
  givenname: Adrien
  surname: Guenego
  fullname: Guenego, Adrien
  organization: PIERRE PAUL RIQUET HOSPITAL, Toulouse, France
– sequence: 6
  givenname: navraj s
  surname: heran
  fullname: heran, navraj s
  organization: Fraser Health Authority, New Westminster, Canada
– sequence: 7
  givenname: William
  surname: Siu
  fullname: Siu, William
  organization: Dept of Medicine: Div of Neurology, Stroke Program, The Ottawa Hosp, Ottawa, Canada
– sequence: 8
  givenname: Cyril
  surname: Dargazanli
  fullname: Dargazanli, Cyril
  organization: Dept of Neuroradiology, Cntr Hospier Universitaire Gui de Chauliac, Montpellier, France
– sequence: 9
  givenname: Amel
  surname: Benali
  fullname: Benali, Amel
  organization: Dept of Neuroradiology, Cntr Hospier Universitaire Gui de Chauliac, Montpellier, France
– sequence: 10
  givenname: Benjamin
  surname: Gory
  fullname: Gory, Benjamin
  organization: CHRU NANCY, Nancy, France
– sequence: 11
  givenname: Sebastien
  surname: Richard
  fullname: Richard, Sebastien
  organization: Dept of Medicine: Div of Neurology, Stroke Program, Université de Lorraine, CHRU-Nancy, F-54000 Nancy, France, France
– sequence: 12
  givenname: Celina
  surname: Ducroux
  fullname: Ducroux, Celina
  organization: Dept of Interventional Neuroradiology, Fondation Rothschild Hosp, Paris, France
– sequence: 13
  givenname: Michel
  surname: Piotin
  fullname: Piotin, Michel
  organization: Rothschild Foundation, Paris, France
– sequence: 14
  givenname: RAPHAEL
  surname: BLANC
  fullname: BLANC, RAPHAEL
  organization: Rothschild Foundation, Paris, France
– sequence: 15
  givenname: Julien
  surname: Labreuche
  fullname: Labreuche, Julien
  organization: Lille, France
– sequence: 16
  givenname: Ludovic
  surname: Lucas
  fullname: Lucas, Ludovic
  organization: Neurovascular Unit, Cntr Hospier Universitaire de Bordeaux, Bordeaux, France
– sequence: 17
  givenname: John
  surname: Haddad
  fullname: Haddad, John
  organization: Doctor of Medicine Program, Univ of Ottawa, Ottawa, Canada
– sequence: 18
  givenname: Mathilde
  surname: Aubertin
  fullname: Aubertin, Mathilde
  organization: Dept of Interventional Neuroradiology, Fondation Rothschild Hosp, Paris, France
– sequence: 19
  givenname: stephane
  surname: vannier
  fullname: vannier, stephane
  organization: RENNES, France
– sequence: 20
  givenname: Maud
  surname: Guillen
  fullname: Guillen, Maud
  organization: Neurovascular Unit, Cntr Hospier Universitaire Pontchaillou, Rennes, France
– sequence: 21
  givenname: Francois
  surname: Eugene
  fullname: Eugene, Francois
  organization: Neurovascular Unit, Cntr Hospier Universitaire Pontchaillou, Rennes, France
– sequence: 22
  givenname: Benjamin
  surname: Maier
  fullname: Maier, Benjamin
  organization: Dept of Interventional Neuroradiology, Fondation Rothschild Hosp, Paris, France
– sequence: 23
  givenname: Gaultier
  surname: Marnat
  fullname: Marnat, Gaultier
  organization: Dept of Neuroradiology, Cntr Hospier Universitaire de Bordeaux, Bordeaux, France
– sequence: 24
  givenname: Lili
  surname: Detraz
  fullname: Detraz, Lili
  organization: Chu Nantes HGRL, Saint Herblain, France
– sequence: 25
  givenname: Romain
  surname: Bourcier
  fullname: Bourcier, Romain
  organization: Dept of Diagnostic and Therapeutic Neuroradiology, Univ Hosp of Nantes, L’institut du thorax, Nantes, France
– sequence: 26
  givenname: Robert
  surname: FAHED
  fullname: FAHED, Robert
  organization: The Ottawa Hosp, Ottawa, Canada
BookMark eNotkN1qwzAMhc3oYG23J9iNXyCZbMeJs7us7KdQ6Bi9N46j0Gz5w04offu5tFcSQp90zlmRRT_0SMgzg5ixlL34ycWSx34ex1az-FsKcUeWTPIkSlKuFmQJIPKIJ3n-QFbe_wIAF0ouSVOUATZ2ohfolW5721TYW6Smr-h-nuzQoadDTQ9HN3Ql2mnozvQHvZ0xzNCZsQkLTU8LO09I34xvWuNo4SZ0Z7q3tp19M_T-kdzXpvX4dKtrcvh4P2y-ot3-c7spdpFVuYqErZJMyISlRiqDeWnylPOSJxnjJdQmy7DMpeIceCLq0Fc1pLwGFWhWohRrIq5nrRu8d1jr0TWdcWfNQF_C0sGvllzfwtIX34FKrtRpaINu_9fOJ3T6iKadjjqkBVmaQRS-MhAALAKQSol_N1lyYQ
ContentType Journal Article
Copyright Lippincott Williams & Wilkins
Copyright_xml – notice: Lippincott Williams & Wilkins
DBID AAYXX
CITATION
DOI 10.1161/str.52.suppl_1.P533
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4628
EndPage AP533
ExternalDocumentID 10_1161_str_52_suppl_1_P533
00007670-202103001-00588
GroupedDBID ---
.XZ
.Z2
01R
0R~
123
1J1
2WC
40H
4Q1
4Q2
4Q3
53G
5RE
5VS
6PF
71W
77Y
7O~
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAUEB
AAXQO
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACDDN
ACDOF
ACEWG
ACGFS
ACGOD
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADGGA
ADHPY
AE3
AE6
AEBDS
AENEX
AFBFQ
AFDTB
AFEXH
AFMBP
AFNMH
AFSOK
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
AYCSE
BAWUL
BCGUY
BOYCO
BQLVK
C45
CS3
DIK
DIWNM
DU5
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
GNXGY
GQDEL
GX1
H0~
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
O9-
OAG
OAH
OB3
ODMTH
OGROG
OHYEH
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
PQQKQ
RAH
RIG
RLZ
S4R
S4S
TEORI
TSPGW
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
XXN
XYM
YFH
ZB8
.3C
.55
.GJ
3O-
A9M
AAQQT
AAYJJ
AAYXX
ACCJW
ADFPA
ADGHP
ADNKB
AEETU
AFFNX
AHRYX
AJNYG
BS7
CITATION
DUNZO
FW0
H13
M18
N4W
N~M
OCUKA
ODA
ORVUJ
OUVQU
P-K
R58
T8P
X7M
YHZ
YQJ
YYP
ZGI
ZZMQN
ID FETCH-LOGICAL-c898-3cd4735416a58ae9ba9622b24712b0fa77eb958220243feb9df062f08c891be53
ISSN 0039-2499
IngestDate Tue Jul 01 01:49:01 EDT 2025
Fri May 16 03:49:15 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue Suppl_1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c898-3cd4735416a58ae9ba9622b24712b0fa77eb958220243feb9df062f08c891be53
ParticipantIDs crossref_primary_10_1161_str_52_suppl_1_P533
wolterskluwer_health_00007670-202103001-00588
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20210301
2021-03-00
PublicationDateYYYYMMDD 2021-03-01
PublicationDate_xml – month: 3
  year: 2021
  text: 20210301
  day: 01
PublicationDecade 2020
PublicationTitle Stroke (1970)
PublicationYear 2021
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
SSID ssj0002385
Score 2.3554125
Snippet BackgroundHematoma expansion (HE) is an important therapeutic target in intracerebral hemorrhage. Recently proposed HE definitions have not been validated, and...
Abstract only Background: Hematoma expansion (HE) is an important therapeutic target in intracerebral hemorrhage. Recently proposed HE definitions have not...
SourceID crossref
wolterskluwer
SourceType Index Database
Publisher
StartPage AP533
Title Abstract P533: Incidence and Outcomes of Thrombectomy Rescue Therapies in Acute Basilar Artery Occlusions
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00007670-202103001-00588
Volume 52
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBASQlzFuMkPvI2U1I0Tm7cMgSa0cRFF21vkJM6I1iVVLkLwj_iXnGOnqSuKxHiJ0rSxE5-v9ufjz-cQ8oLrTBRhDtNUpaQXqDzzpJ8Jr-BBESAFj3zc4HzyITz6Grw_42eTyS9HtdR36TT7uXNfyf9YFa6BXXGX7BUsOxYKF-Ac7AtHsDAc_8nGcYqOiqw7-AR0Cuf28G-3SULNmsDHvoNabVTZxbemvkzRRX-JrLvNeo1qi0atSiPJOogzVAwcqrZEXWqMSs8fGIN42bejS28gsV-6pr4w3HQmI9_xJRz3dkZfO_P8U7UchBu4HWaT5PlUl62Nu6Ab77i0qmZHYY-xIFe6Oe_NF4e6gTetctdJwRyVlnVS7Ag2YZwU5RKVQG4HPccFH5szad1Bc-YA0SQ7TWZOnxtjGzsD-Pj5z9EhxNEBLDPlDMYmU9B0c_dW2G2zxhtGvoevA6BFr4vPhbhGrrMIaBqu_3_eBKYH5mOTZQzPPwS4ghpf7ahviwTd-l6jMKK9MPsiHHazuENuD9MSGluM3SUTXd0jN04G4cV9Uq6hRrHg13QEGgWj0DXQaF1QF2jUAo2OQKNlRQ3Q6AA0aoFGN0B7QBbv3i7eHHlDlg4vE1J48yzH7NXA6xUXSstUyZCxlAHpYalfqCjSqeRAQzH0ZQHneeGHrPAF3D1LNZ8_JHtVXelHhIowFEwCgcwKE7VISKl9jQmJQh7oXO6Tl-tWS1Y2Fkti5rDhLIE2SDhLhkZOsC32ibfVsondWZz8zbKPr_j7J-TmBupPyV7X9PoZMNQufW6w8RvUZo28
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abstract+P533%3A+Incidence+and+Outcomes+of+Thrombectomy+Rescue+Therapies+in+Acute+Basilar+Artery+Occlusions&rft.jtitle=Stroke+%281970%29&rft.au=Lun%2C+Ronda&rft.au=Walker%2C+Greg+B&rft.au=Weisenburger-Lile%2C+David&rft.au=Lapergue%2C+Bertrand&rft.date=2021-03-01&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=0039-2499&rft.volume=52&rft.issue=Suppl_1&rft.spage=AP533&rft.epage=AP533&rft_id=info:doi/10.1161%2Fstr.52.suppl_1.P533&rft.externalDocID=00007670-202103001-00588
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon